Aquinox Pharmaceuticals
Country
Canada
Краткое название
Aquinox Pharmaceuticals
Headquarters
Suite 430 - 5600 Parkwood Way
Members of the board
Mr. David J. Main, President & CEO
Dr. Thomas MacRury, Ph.D., EVP & Chief Operating Officer
Dr. David Chernoff, M.D., Chief Medical Officer
Mr. Kamran Alam, VP Finance & Chief Financial Officer
Mr. Lloyd Mackenzie, Senior Director, Technical Operations
Dr. Patrick Tam, Ph.D., Director, Product Development
Dr. Thomas MacRury, Ph.D., EVP & Chief Operating Officer
Dr. David Chernoff, M.D., Chief Medical Officer
Mr. Kamran Alam, VP Finance & Chief Financial Officer
Mr. Lloyd Mackenzie, Senior Director, Technical Operations
Dr. Patrick Tam, Ph.D., Director, Product Development
Categories medicine
Oncology
Stage of the project
Production
Disease
Lung cancer
Current owners
Mr. Kenneth Galbraith, General Partner, Ventures West Capital
Mr. Frank Holler, President & CEO, Lion`s Capital Corporation
Dr. Elaine Jones, Executive Director, Pfizer Venture Investments
Dr. Daniel Levitt, Chief Medical Officer, CytRx Corporation
Mr. David J. Main, Chairman, President & CEO, Aquinox Pharmaceuticals Inc.
Dr. Asish Xavier, Vice President, Johnson & Johnson Development Corporation
Mr. Frank Holler, President & CEO, Lion`s Capital Corporation
Dr. Elaine Jones, Executive Director, Pfizer Venture Investments
Dr. Daniel Levitt, Chief Medical Officer, CytRx Corporation
Mr. David J. Main, Chairman, President & CEO, Aquinox Pharmaceuticals Inc.
Dr. Asish Xavier, Vice President, Johnson & Johnson Development Corporation
Technology
Pharmaceuticals